Dyne Therapeutics (DYN) Preferred Shares (2019)

Dyne Therapeutics' (DYN) quarterly Preferred Shares came in at $27.4 million in Q4 2019.

Dyne Therapeutics (DYN) Preferred Shares (2019) Analysis & Trends

Dyne Therapeutics (DYN) has 1 years of Preferred Shares data on file, last reported at $27.4 million in Q4 2019.

On a quarterly basis, Preferred Shares changed N/A year-over-year to $27.4 million in Q4 2019; TTM through Dec 2019 was $27.4 million, a N/A change from a year earlier, with the FY2019 full-year figure at $27.4 million, changed N/A from the prior year.
Preferred Shares for Q4 2019 stood at $27.4 million.
Over the last five years, Preferred Shares for DYN reached as high as $27.4 million in Q4 2019 and fell as low as $27.4 million in Q4 2019.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Shares (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	-
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	-
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Dyne Therapeutics	3.94 Bn	3.94 Bn	-	-

Historic Data

Download Data

Date	Value
Dec 31, 2019	27.43 Mn